Abstract
This letter to the editor remarks on a recently published article reporting on gemcitabine‐related adverse events associated with antibacterial use, focusing on key points for further consideration.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Anti-Bacterial Agents* / adverse effects
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives
-
Gemcitabine
-
Humans
-
Pancreatic Neoplasms* / drug therapy
Substances
-
Anti-Bacterial Agents
-
Deoxycytidine
-
Gemcitabine